Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06082778
Other study ID # ZHS-FE
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 9, 2023
Est. completion date November 6, 2023

Study information

Verified date October 2023
Source Zoe Global Limited
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is not known if an increase in fermented food intake relative to an individuals' habitual diet can lead to improvements in bloating, mood, or hunger levels, or increase energy levels (and reduce fatigue) in the general population. Acceptability of fermented foods across many different types of people and households is also unclear. Therefore, this research aims to investigate the potential effects of increasing fermented food intake on these outcomes, as well as the feasibility of this dietary change.


Description:

Background: Fermented foods (e.g., kombucha, kimchi, sauerkraut) are living foods containing an ecosystem of bacteria and yeasts that use enzymes to process and transform food components. The process of fermentation results in an enhanced nutritional profile of these foods (including probiotics, prebiotics, and additional vitamins) which are associated with health benefits. The majority of people in the Western world consume low amounts of fermented food with live cultures; ~70% report never or rarely consuming fermented foods. Existing research demonstrates that there are benefits to consuming fermented foods, including improvement of gut microbiome composition as well as reducing inflammation. Furthermore, fermented foods are a unique source of B vitamins that are related to energy levels. Low energy levels are a common but complex problem that affects healthy individuals as well as those with chronic health conditions. Whilst the underlying causes of low energy are unclear, they are a common complaint of many digestive disorders, autoimmune, chronic inflammatory conditions, and metabolic and mood disorders, all of which are associated with disturbance of the gut microbiome. Humans are unable to produce B vitamins and are reliant on diet or gut microbes to produce them. Vitamin B12 levels are ten fold greater in fermented dairy products, and can be found in fermented plant-based foods such as tempeh, making these foods a valuable source of vitamin B12, a nutrient that the human diet is commonly deficient in. Fermented foods may have the potential to improve energy, and mood, by increasing gut diversity and reducing inflammation. Population: This research is open to participants who are enrolled in the ZOE Health Study. Participants must be at least 18 years of age and must provide their consent in order to participate. Design: The Fermented Foods study will take place in an entirely remote format. This study will take part in two phases. Firstly, the participant will complete a habitual diet phase lasting one week, where the participant reports study outcomes while consuming their habitual diet (including habitual intake level of fermented foods). Secondly, the participant will complete the modification phase lasting two weeks, throughout which they are required to introduce, or increase, their habitual intake of fermented foods by three portions per day (e.g., where a participant normally consumes 1 serving per day, they will now be asked to consume 4 servings per day). Using the ZOE Health Study app, participants will be asked to: - Complete questionnaires to assess habitual food intake, dietary habits, health history, sleep, bowel habits and digestive health at the start and end of the study. - Log levels of hunger, energy, mood and bloating, on a daily basis, throughout the entire study period (baseline and modification phase) using the study app. - Log their portion intake of fermented foods, on a daily basis, throughout the entire study period.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50000
Est. completion date November 6, 2023
Est. primary completion date November 6, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All adults aged 18 - Able to give informed consent - Are participants of the ZOE Health Study - Reside in the UK. Exclusion Criteria: Participants will be excluded if they are: - Below the age of 18 years. - Have an histamine intolerance. - Have a compromised immune system. - Have been instructed to follow a salt-restricted diet. - Consume 8 or more portions of fermented foods on a daily basis at baseline

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Fermented food intake above habitual level
Participants increase their habitual intake of fermented foods by three portions per day, compared to their habitual intake level at baseline.

Locations

Country Name City State
United Kingdom ZOE Ltd London England

Sponsors (1)

Lead Sponsor Collaborator
Zoe Global Limited

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in digestive symptoms Participants will self-report their commonly experienced digestive symptoms and those that they receive treatment for, at both baseline and wk-3. 3 weeks
Other Change in bowel movements Participants will self-report their average frequency of bowel movements at baseline and wk-3. 3 weeks
Other Change in stool form Participants will self-report the most common form of their stool form at baseline and wk-3 using the Bristol Stool Form Scale. This scale ranges from 1 to 7, with lower values indicating constipation (1-2), whereas higher values (5-7) may indicate diarrhoea and urgency. 3 weeks
Primary Daily energy level Participants will self-report their energy level daily using a Visual Analogue Scale ranging from 0 to 10. Higher scores represent better outcomes. 3 weeks
Secondary Daily sensation of abdominal bloating Participants will self-report their severity of abdominal bloating daily using a Visual Analogue Scale ranging from 0 to 10. Higher scores represent worse outcomes. 3 weeks
Secondary Change in mood Participants will self-report their mood at baseline and wk-3 using a modified version of the Visual Analogue Mood Scale (VAMS) in response to questions about specific mood states (Happy, Sad, Calm, Tense, Energetic, Sleepy). The scale ranges from 0 to 100, with higher scores representing better outcomes for 'Happy', 'Calm' and 'Energetic'; and worse outcomes for 'Sad', 'Tense' and 'Sleepy'. 3 weeks
Secondary Daily level of mood Participants will self-report their mood daily, using a Visual Analogue Scale ranging from 0 to 10. Higher scores represent better outcomes. 3 weeks
Secondary Change in hunger level Participants will self-report their hunger level at baseline and wk-3, in response to questions about specific hunger symptoms, with answer options following a Likert scale ranging from 'strongly agree' to 'strongly disagree'. 3 weeks
Secondary Daily hunger level Participants will self-report their hunger level daily, using a Visual Analogue Scale ranging from 0 to 10. Higher scores represent worse outcomes. 3 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05516264 - Behavioural and Physiological Responses to Dog Visits in Nursing Homes N/A
Completed NCT05555186 - The Effects of Bright Light Therapy on Adolescent's Sleep Quality and Well-being N/A
Completed NCT04706806 - Effect of Daily Vinegar Ingestion for Four Weeks on Mood State in Healthy College Students N/A
Completed NCT04013451 - The Kiss of Kindness Study II N/A
Completed NCT03689348 - Acute and Chronic Effects of Avena Sativa on Cognition and Stress N/A
Completed NCT04440553 - A Mobile App to Increase Physical Activity in Students N/A
Completed NCT04505800 - Tryptophan Supplementation to Improve Night Shift Workers' Health N/A
Completed NCT05100589 - Effect of PeakATP on Mood, Reaction Time and Cognition N/A
Completed NCT05559372 - Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes N/A
Active, not recruiting NCT04641689 - Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment N/A
Active, not recruiting NCT01725425 - The Effect of Portion Sizes on Mood N/A
Completed NCT01794351 - Cognitive Effects of 500mg Trans-resveratrol N/A
Completed NCT05550610 - Evaluation of Mindfulness and Yoga in Basic Combat Training N/A
Recruiting NCT05939453 - Impact of Bright Light Therapy on Prader-Willi Syndrome N/A
Recruiting NCT05058872 - Contraceptive Hormone and Reward Measurement (CHARM Study) Phase 4
Not yet recruiting NCT04551274 - Music Therapy in Frontline Healthcare Workers N/A
Completed NCT03105973 - Technology Enabled Mental Health Intervention for Individuals in the Criminal Justice System N/A
Completed NCT04075448 - The Acute Effect of a Walnut Intervention on Cognitive Performance, Brain Activation, and Serum Markers of Inflammation in Young Adults N/A
Completed NCT05721521 - The Effects of Exercise Intensity on Mood and Wellbeing N/A